Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

25.86
Delayed Data
As of Jun 28
 +2.81 / +12.19%
Today’s Change
14.84
Today|||52-Week Range
39.90
-16.50%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close23.05
Today’s open23.67
Day’s range23.53 - 27.00
Volume422,542
Average volume (3 months)297,614
Market cap$893.4M
Dividend yield--
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)+55.00%
Earnings growth (this year)-286.58%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.00%
P/E ratioNM
Price/Sales9.77
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+1.46+6.22%
FWPForward Pharma A/S+0.96+5.72%
SRPTSarepta Therapeutics...+0.86+5.07%
INSYINSYS Therapeutics I...+0.82+7.16%
Data as of 06/28/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$100.9M
Annual profit (last year)-$20.1M
Net profit margin-19.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers

Search for Jobs